Diacartaincis A Precision Molecular Diagnostics Company Based In Pleasantoncaliforniafounded In 2011 By Aiguo Zhang And Drpaul Okunieffthe Company Focuses On Improving The Lives Of Cancer Patients Through Innovative And Accurate Diagnostic Solutionsdiacarta Is Committed To Making Diagnostics Accessibleoffering Quick And Affordable Testing Options The Company Provides A Comprehensive Range Of Diagnostic Products And Servicesincluding Early Detectiondiagnosistherapy Selectionand Therapy Monitoringits Proprietary Technologiessuch As Xna And Isobdnafacilitate Sensitive Detection Of Genetic Alterationskey Offerings Include Radtoxa Ccoloscapea Concuriaa Hpv Testsand Monkeypox Testsalong With Covid 19 Testing Kits Developed During The Pandemic With A Revenue Of Approximately $30 Million And Around 53 Employeesdiacarta Is Focused On Advancing Precision Diagnostics Through Research And Collaborationthe Company Is Also Planning To Go Public Through A Mergerwhich Aims To Support Its Growth And Innovation In The Healthcare Sector
